# CRBP (Corbus Pharmaceuticals Holdings, Inc.) - SEC EDGAR Financial Statements

> Corbus Pharmaceuticals Holdings, Inc. reported $122.9M in total assets and a net loss of $116.3M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CRBP
- Markdown: https://convexityos.com/fundamentals/CRBP.md
- SEC CIK: 0001595097
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:51 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001595097&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$121.3M | Operating profit |
| Net Income | FY 2025 | -$116.3M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$5.58 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$92.39M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $115.3M | Total debt: $3.91M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $882K | $3.94M | $36.14M | $4.82M | $2.44M | $1.91M |
| Research & Development | $70.09M | $32.22M | $31.17M | $16.14M | $36.45M | $98.27M | $89.60M | $48.61M | $26.04M | $15.44M |
| Total Operating Expenses | $85.31M | $48.72M | $45.08M | $39.84M | $56.87M | $126.7M | $113.2M | $61.57M | $35.00M | $21.90M |
| **Operating Income** | -$85.31M | -$48.72M | -$45.08M | -$39.84M | -$55.99M | -$122.8M | -$77.10M | -$56.75M | -$32.56M | -$19.99M |
| **EBITDA** | -$85.08M | -$48.13M | -$44.44M | -$39.07M | -$54.99M | -$121.7M | -$76.37M | -$56.25M | -$32.31M | -$19.90M |
| Interest Income | -- | -- | -- | -- | -- | -- | $1.23M | $983K | -- | -- |
| Interest Expense | $0 | $1.87M | $3.86M | $3.10M | $2.71M | $1.13M | $0 | -- | $3.6K | $3.1K |
| Income Tax Expense | $0 | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$78.54M | -$40.21M | -$44.60M | -$42.35M | -$45.64M | -$111.3M | -$71.45M | -$55.67M | -$32.42M | -$20.00M |
| Basic EPS | -$5.90 | -$3.68 | -$10.31 | -$10.15 | -$11.15 | -$42.64 | -$33.63 | -$29.43 | -$19.52 | -$14.71 |
| **Diluted EPS** | -$5.90 | -$3.68 | -$10.31 | -$10.15 | -$11.15 | -$42.64 | -$33.63 | -$29.43 | -$19.52 | -$14.71 |
| Basic Shares Outstanding | 13.3M | 10.9M | 4.3M | 4.2M | 4.1M | 2.6M | 2.1M | 1.9M | 1.7M | 1.4M |
| Diluted Shares Outstanding | 13.3M | 10.9M | 4.3M | 4.2M | 4.1M | 2.6M | 2.1M | 1.9M | 1.7M | 1.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $34.25M | $31.18M | $19.82M | $18.41M | $20.86M | $15.19M | $15.64M | $8.79M |
| Total Operating Expenses | $38.82M | $36.19M | $24.30M | $21.97M | $24.42M | $19.15M | $19.77M | $12.61M |
| **Operating Income** | -$38.82M | -$36.19M | -$24.30M | -$21.97M | -$24.42M | -$19.15M | -$19.77M | -$12.61M |
| **EBITDA** | -$38.77M | -$36.14M | -$24.25M | -$21.92M | -$24.37M | -$19.10M | -$19.69M | -$12.47M |
| Interest Expense | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$37.75M | -$35.04M | -$22.97M | -$20.55M | -$23.34M | -$17.66M | -$16.98M | -$9.53M |
| Basic EPS | -$1.81 | -$1.81 | -$1.23 | -- | -$1.90 | -$1.44 | -$1.39 | -- |
| **Diluted EPS** | -$1.81 | -$1.81 | -$1.23 | -- | -$1.90 | -$1.44 | -$1.39 | -- |
| Basic Shares Outstanding | 20.8M | 19.4M | 18.7M | -- | 12.3M | 12.2M | 12.2M | -- |
| Diluted Shares Outstanding | 20.8M | 19.4M | 18.7M | -- | 12.3M | 12.2M | 12.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $28.49M | $17.20M | $13.72M | $17.00M | $25.01M | $85.43M | $31.75M | $41.75M | $62.54M | $14.99M |
| Short-Term Investments | $134.8M | $131.9M | $7.18M | $42.19M | $72.64M | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $163.3M | $149.1M | $20.91M | $59.20M | $97.65M | $85.43M | $31.75M | $41.75M | $62.54M | $14.99M |
| **Total Current Assets** | $167.0M | $153.0M | $23.55M | $60.18M | $100.2M | $92.07M | $38.15M | $44.24M | $65.50M | $17.40M |
| Property, Plant & Equipment, Net | $159K | $385K | $973K | $1.61M | $2.39M | $4.07M | $5.08M | $2.71M | $1.43M | $435K |
| Other Non-Current Assets | -- | $0 | $212K | $155K | $46K | $234K | $85K | $44K | $41K | -- |
| **Total Non-Current Assets** | $1.24M | $2.90M | $4.73M | $6.13M | $7.53M | $10.22M | $10.99M | $2.75M | $1.47M | $485K |
| **Total Assets** | $168.2M | $155.9M | $28.27M | $66.31M | $107.7M | $102.3M | $49.14M | $46.99M | $66.98M | $17.89M |
| Accounts Payable | $2.21M | $4.79M | $3.18M | $2.17M | $1.78M | $7.38M | $11.09M | $6.35M | $3.13M | $3.42M |
| Short-Term Debt | -- | -- | $15.91M | $2.80M | $3.09M | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $1.46M | -- | $1.94M |
| **Total Current Liabilities** | $20.69M | $11.82M | $31.89M | $12.64M | $17.01M | $31.90M | $34.89M | $18.09M | $8.20M | $8.90M |
| Long-Term Debt | -- | -- | $0 | $15.98M | $15.64M | $18.03M | -- | -- | -- | -- |
| Other Non-Current Liabilities | -- | $0 | $44K | $22K | $22K | -- | -- | -- | $375 | $4.6K |
| **Total Non-Current Liabilities** | $0 | $1.63M | $3.28M | $20.68M | $21.61M | $25.12M | $8.10M | $1.38M | $990K | $70K |
| **Total Liabilities** | $20.69M | $13.45M | $35.18M | $33.32M | $38.62M | $57.02M | $42.98M | $19.47M | $9.19M | $8.97M |
| **Total Debt (incl. Leases)** | $1.63M | $3.24M | $20.58M | $24.74M | $25.82M | $26.13M | $8.69M | $1.41M | -- | -- |
| Common Stock | $2.0K | $1.0K | $0 | $417 | $416 | $9.9K | $6.5K | $5.7K | $5.6K | $4.5K |
| Retained Earnings | -$555.4M | -$476.9M | -$436.7M | -$392.1M | -$349.7M | -$304.1M | -$192.8M | -$121.4M | -$65.70M | -$33.28M |
| Accumulated Other Comp. Income | -$53K | $35K | -$1.0K | -$126K | -$62K | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $147.5M | $142.4M | -$6.91M | $32.99M | $69.11M | $45.27M | $6.16M | $27.52M | $57.78M | $8.92M |
| Total Equity | $147.5M | $142.4M | -$6.91M | $32.99M | $69.11M | $45.27M | $6.16M | $27.52M | $57.78M | $8.92M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $30.25M | $23.37M | $25.66M | $28.49M | $26.98M | $20.04M | $18.90M | $17.20M |
| Short-Term Investments | $85.09M | $94.57M | $112.6M | $134.8M | $77.00M | $96.55M | $113.9M | $131.9M |
| **Cash & Short-Term Investments** | $115.3M | $117.9M | $138.2M | $163.3M | $104.0M | $116.6M | $132.8M | $149.1M |
| **Total Current Assets** | $119.0M | $122.8M | $143.6M | $167.0M | $107.6M | $122.8M | $137.4M | $153.0M |
| Property, Plant & Equipment, Net | $36K | $71K | $116K | $159K | $201K | $251K | $304K | $385K |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $3.95M | $4.24M | $914K | $1.24M | $1.94M | $2.26M | $2.57M | $2.90M |
| **Total Assets** | $122.9M | $127.0M | $144.5M | $168.2M | $109.5M | $125.1M | $139.9M | $155.9M |
| Accounts Payable | $4.07M | $5.25M | $435K | $2.21M | $2.74M | $3.99M | $4.07M | $4.79M |
| **Total Current Liabilities** | $34.97M | $21.48M | $18.14M | $20.69M | $17.06M | $13.33M | $11.62M | $11.82M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $3.18M | $3.27M | $0 | $0 | $307K | $761K | $1.21M | $1.63M |
| **Total Liabilities** | $38.14M | $24.75M | $18.14M | $20.69M | $17.37M | $14.09M | $12.82M | $13.45M |
| **Total Debt (incl. Leases)** | $3.91M | $4.26M | $1.21M | $1.63M | $2.05M | $2.46M | $2.85M | $3.24M |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$651.2M | -$613.4M | -$578.4M | -$555.4M | -$534.9M | -$511.5M | -$493.9M | -$476.9M |
| Accumulated Other Comp. Income | -$196K | -$107K | -$161K | -$53K | -$3.0K | -$39K | -$23K | $35K |
| **Total Stockholders' Equity** | $84.76M | $102.2M | $126.3M | $147.5M | $92.15M | $111.0M | $127.1M | $142.4M |
| Total Equity | $84.76M | $102.2M | $126.3M | $147.5M | $92.15M | $111.0M | $127.1M | $142.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$78.54M | -$40.21M | -$44.60M | -$42.35M | -$45.64M | -$111.3M | -$71.45M | -$55.67M | -$32.42M | -$20.00M |
| Depreciation & Amortization | $233K | $588K | $641K | $763K | $1000K | $1.12M | $739K | $494K | $256K | $88K |
| Stock-Based Compensation | $6.29M | $6.14M | $3.47M | $5.72M | $9.48M | $12.46M | $11.98M | $7.61M | $5.69M | $3.16M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | $5.00M | $12.50M | $1.00M | -$1.00M |
| Change in Payables | -$2.35M | $1.60M | $1.03M | -$257K | -$5.96M | -$3.47M | $4.37M | $3.90M | -$886K | $1.89M |
| **Operating Cash Flow** | -$64.49M | -$41.79M | -$36.10M | -$37.54M | -$48.18M | -$99.69M | -$45.72M | -$30.07M | -$27.80M | -$13.57M |
| Capital Expenditure | -$7.0K | $0 | $0 | -$13K | -$54K | -$484K | -$2.74M | -$2.30M | -$707K | -$353K |
| **Free Cash Flow** | -$64.50M | -$41.79M | -$36.10M | -$37.56M | -$48.24M | -$100.2M | -$48.46M | -$32.37M | -$28.50M | -$13.92M |
| Purchases of Investments | -$163.1M | -$180.8M | -$33.88M | -$86.34M | -$87.27M | -- | -- | -- | -- | -- |
| Sales & Maturities of Investments | $161.5M | $59.49M | $69.53M | $116.4M | $13.88M | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$1.64M | -$121.3M | $35.64M | $30.07M | -$73.42M | -$484K | -$2.74M | -$2.30M | -$707K | -$353K |
| Common Stock Issued | $77.43M | $182.1M | $53K | -- | $62.59M | $142.2M | $40.68M | $12.05M | $78.89M | $16.70M |
| **Financing Cash Flow** | $77.43M | $166.6M | -$2.82M | -$534K | $60.82M | $154.9M | $38.46M | $11.42M | $76.01M | $16.74M |
| **Net Change in Cash** | $11.29M | $3.47M | -$3.28M | -$8.00M | -$60.78M | $54.70M | -$10.00M | -$20.95M | $47.50M | $2.82M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$37.75M | -$35.04M | -$22.97M | -$20.55M | -$23.34M | -$17.66M | -$16.98M | -$9.53M |
| Depreciation & Amortization | $50K | $51K | $49K | $49K | $50K | $53K | $81K | $134K |
| Stock-Based Compensation | $1.81M | $1.81M | $1.92M | $1.43M | $1.58M | $1.56M | $1.71M | $1.63M |
| Change in Payables | -$1.19M | $4.81M | -$1.87M | -$564K | -$1.28M | $175K | -$684K | $1.68M |
| **Operating Cash Flow** | -$21.24M | -$29.63M | -$25.57M | -$15.92M | -$15.55M | -$16.60M | -$16.42M | -$10.94M |
| Capital Expenditure | -$15K | -$6.0K | -$6.0K | -$7.0K | $0 | $0 | $0 | -- |
| **Free Cash Flow** | -$21.25M | -$29.63M | -$25.58M | -$15.93M | -$15.55M | -$16.60M | -$16.42M | -- |
| Purchases of Investments | -$43.92M | -$8.70M | -$10.73M | -$90.02M | -$17.84M | -$17.62M | -$37.60M | -$11.24M |
| Sales & Maturities of Investments | $53.49M | $26.96M | $33.19M | $32.88M | $37.48M | $35.37M | $55.73M | $19.97M |
| **Investing Cash Flow** | $9.56M | $18.26M | $22.45M | -$57.15M | $19.64M | $17.74M | $18.12M | $8.73M |
| Common Stock Issued | -- | -- | -- | $74.58M | $2.85M | $0 | $0 | -$13K |
| **Financing Cash Flow** | -- | -- | -- | $74.58M | $2.85M | $0 | $0 | -$13K |
| **Net Change in Cash** | $6.88M | -$2.29M | -$3.12M | $1.51M | $6.94M | $1.14M | $1.70M | -$2.23M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -6350.1% | -3119.2% | -213.3% | -1176.8% | -1334.4% | -1045.6% |
| **Net Profit Margin** | -- | -- | -- | -- | -5176.4% | -2826.1% | -197.7% | -1154.5% | -1328.6% | -1046.3% |
| Return on Equity (ROE) | -53.2% | -28.2% | -- | -128.4% | -66.0% | -245.8% | -1160.4% | -202.3% | -56.1% | -224.2% |
| Return on Assets (ROA) | -46.7% | -25.8% | -157.8% | -63.9% | -42.4% | -108.8% | -145.4% | -118.5% | -48.4% | -111.8% |
| Current Ratio | 8.07x | 12.94x | 0.74x | 4.76x | 5.89x | 2.89x | 1.09x | 2.45x | 7.98x | 1.96x |
| Quick Ratio | 7.89x | 12.61x | 0.66x | 4.68x | 5.74x | 2.68x | 0.91x | 2.31x | 7.62x | 1.68x |
| Debt to Equity | 0.01x | 0.02x | -- | 0.75x | 0.37x | 0.58x | 1.41x | 0.05x | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | -77.6% | -89.1% | +649.5% | +97.6% | +27.7% | +194.8% |
| 5Y Revenue / Share Growth | -- | -- | -- | -100.0% | -84.6% | +143.6% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -137.2% | -99.7% | -66.9% | -53.2% | -73.3% | -52.2% | -39.6% | -28.2% |
| Return on Assets (ROA) | -94.6% | -80.2% | -58.5% | -46.7% | -61.6% | -46.3% | -35.9% | -25.8% |
| Current Ratio | 3.40x | 5.71x | 7.92x | 8.07x | 6.31x | 9.21x | 11.82x | 12.94x |
| Quick Ratio | 3.30x | 5.49x | 7.62x | 7.89x | 6.10x | 8.74x | 11.43x | 12.61x |
| Debt to Equity | 0.05x | 0.04x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
